Chunling Hu Selected Research

Drug Therapy (Chemotherapy)

1/2021	Integrating Network Pharmacology, Transcriptome and Artificial Intelligence for Investigating Into the Effect and Mechanism of Ning Fei Ping Xue Decoction Against the Acute Respiratory Distress Syndrome.
12/2020	Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma.
4/2019	Facile Fabrication of Nanoscale Porphyrinic Covalent Organic Polymers for Combined Photodynamic and Photothermal Cancer Therapy.
1/2018	BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.
1/2015	Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunling Hu Research Topics

Disease

28	Neoplasms (Cancer) 01/2023 - 06/2003
13	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2017
9	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 11/2010
5	Neoplasm Metastasis (Metastasis) 09/2020 - 03/2013
4	Triple Negative Breast Neoplasms 11/2021 - 01/2018
4	Infections 11/2010 - 04/2004
3	Fibrosis (Cirrhosis) 02/2023 - 06/2013
3	Carcinogenesis 12/2021 - 06/2003
2	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2023 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 11/2017
2	Acute Lung Injury 01/2022 - 03/2020
2	Inflammation (Inflammations) 12/2021 - 03/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 06/2003
2	Hypoxia (Hypoxemia) 02/2021 - 01/2020
2	Multiple Myeloma 01/2021 - 06/2017
1	Cholangiocarcinoma 10/2022
1	Second Primary Neoplasms (Neoplasms, Second) 09/2022
1	Sepsis (Septicemia) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Starvation 02/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Confusion (Bewilderment) 01/2021
1	Edema (Dropsy) 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Pulmonary Edema 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Hyperthermia 01/2020
1	Fatty Liver 01/2020
1	Chromosome Fragility 01/2019

Drug/Important Bio-Agent (IBA)

9	SulfatasesIBA 01/2020 - 11/2010
8	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2004
8	Estrogen ReceptorsIBA 01/2023 - 12/2017
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2010
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 04/2019
4	Messenger RNA (mRNA)IBA 01/2020 - 09/2004
3	Adenosine Monophosphate (AMP)IBA 02/2024 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 09/2022 - 04/2015
2	ORALIT (ORS)IBA 12/2023 - 12/2020
2	Peptides (Polypeptides)IBA 02/2023 - 04/2004
2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2021
2	LipopolysaccharidesIBA 01/2022 - 03/2020
2	Transforming Growth Factor-beta Type II ReceptorIBA 12/2021 - 01/2018
2	Therapeutic UsesIBA 02/2021 - 07/2019
2	AntioxidantsIBA 02/2021 - 01/2020
2	Progesterone Receptors (Progesterone Receptor)IBA 12/2020 - 01/2018
2	AntigensIBA 09/2020 - 01/2020
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2017 - 04/2015
2	GlypicansIBA 11/2010 - 11/2010
1	EnzymesIBA 02/2023
1	Pepsin A (Pepsin)IBA 02/2023
1	TrypsinIBA 02/2023
1	Coloring Agents (Dyes)IBA 10/2022
1	Long Noncoding RNAIBA 01/2022
1	HMGB1 Protein (HMG1)IBA 01/2022
1	ABO Blood-Group SystemIBA 01/2022
1	Blood Group Antigens (Blood Groups)IBA 01/2022
1	tanreqingIBA 01/2022
1	Sirtuin 1IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	CytokinesIBA 01/2022
1	NucleotidesIBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 02/2021
1	gluconic acid (gluconate)FDA LinkGeneric 02/2021
1	CatalaseIBA 02/2021
1	Glutathione (Reduced Glutathione)IBA 02/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	SalicylatesIBA 01/2021
1	selinexorIBA 01/2021
1	choline salicylateIBA 01/2021
1	PlatinumIBA 12/2020
1	Hydroxyl RadicalIBA 09/2020
1	fibroblast growth factor 21IBA 03/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	LigandsIBA 01/2020
1	Metal-Organic FrameworksIBA 07/2019
1	Photosensitizing Agents (Photosensitizers)IBA 07/2019
1	Oxygen (Dioxygen)IBA 04/2019
1	PolymersIBA 04/2019
1	diepoxybutaneIBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	olaparibIBA 01/2019

Therapy/Procedure

14	Therapeutics 02/2023 - 07/2006
5	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
4	Photothermal Therapy 01/2020 - 04/2019
3	Photochemotherapy (Photodynamic Therapy) 01/2020 - 04/2019
2	Precision Medicine 07/2019 - 01/2018
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Lasers (Laser) 01/2020
1	Castration 01/2019